Coronary computed tomography angiography-based assessment of vascular inflammation in patients with obstructive sleep apnoea and coronary artery disease

Jeremy Yuvaraj; William Cameron; Jordan Andrews; Andrew Lin; Nitesh Nerlekar; Stephen J Nicholls; Garun S Hamilton; Dennis T L Wong

doi:10.21037/cdt-21-338

Coronary computed tomography angiography-based assessment of vascular inflammation in patients with obstructive sleep apnoea and coronary artery disease

Cardiovasc Diagn Ther. 2022 Feb;12(1):123-134. doi: 10.21037/cdt-21-338.

Authors

Jeremy Yuvaraj^{1

2}, William Cameron¹, Jordan Andrews³, Andrew Lin^{1

2}, Nitesh Nerlekar^{1

2}, Stephen J Nicholls^{1

2

3}, Garun S Hamilton^{2

4}, Dennis T L Wong^{1

2}

Affiliations

¹ Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University and MonashHeart, Monash Health, Clayton, Melbourne, VIC, Australia.
² School of Clinical Sciences, Monash University, Clayton, Melbourne, VIC, Australia.
³ South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
⁴ Department of Lung and Sleep Medicine, Monash Health, Clayton, Melbourne, VIC, Australia.

Abstract

Background: Obstructive sleep apnoea (OSA) is associated with increased coronary artery disease (CAD) plaque burden, but the role of vascular inflammation in this relationship is unclear. Coronary computed tomography angiography (CTA) enables surrogate assessment of systemic inflammation via subcutaneous adipose tissue attenuation (SCAT-a), and of coronary inflammation via epicardial adipose tissue volume and attenuation (EAT-v and EAT-a) and pericoronary adipose tissue attenuation (PCAT-a). We investigated whether patients with severe OSA and high plaque burden have increased vascular inflammation.

Methods: Patients with overnight polysomnography within ≤12 months of coronary CTA were included. Severe OSA was classified as apnoea/hypopnoea index (AHI) >30. High plaque burden was defined as a CT-adapted Leaman score (CT-LeSc) ≥8.3. Patients with both severe OSA and high plaque burden were defined as 'Group 1', all other patients were classified as 'Group 2'. ScAT, PCAT and EAT attenuation and volume were assessed on semi-automated software.

Results: A total of 91 patients were studied (59.3±11.1 years). Severe OSA was associated with high plaque burden (P=0.02). AHI correlated with CT-LeSc (r=0.24, P=0.023). Group 1 had lower EAT-a and PCAT-a compared to Group 2 (EAT-a: -87.6 vs. -84.0 HU, P=0.011; PCAT-a: -90.4 vs. -83.4 HU, P<0.01). However, among patients with low plaque burden, EAT-a was higher in the presence of severe OSA versus mild-moderate OSA (-80.3 vs. -84.0 HU, P=0.020). On multivariable analysis, severe OSA and high plaque burden associated with EAT-a (P<0.02), and severe OSA and high plaque burden (P<0.01) and hypertension (P<0.01) associated with PCAT-a.

Conclusions: EAT and PCAT attenuation are decreased in patients with severe OSA and high plaque burden, but EAT attenuation was increased in patients with severe OSA and low plaque burden. These divergent results suggest vascular inflammation may be increased in OSA independent of CAD, but larger studies are required to validate these findings.

Keywords: Obstructive sleep apnoea (OSA); coronary artery disease (CAD); coronary computed tomography angiography (coronary CTA); epicardial adipose tissue (EAT); pericoronary adipose tissue.